Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients.
Huxley S, Moriarty J, Hlatky MA, Lennon R, Bailey K, Bell M, Geller N, Lerman A, Mathew V, Rosenberg Y, Farkouh M, Rihal C, Borah B, Pereira NL.
Huxley S, et al. Among authors: lennon r.
Pharmacogenomics J. 2024 Oct 8;24(6):32. doi: 10.1038/s41397-024-00353-y.
Pharmacogenomics J. 2024.
PMID: 39379363
Clinical Trial.